Souhaitez-vous accéder aux communiqués récents ?

MIRA advances MIRA-55 and SKNY-1 through exploratory toxicology, CMC and manufacturing activities supporting future IND-enabling studies.

Ahead of the official opening of AGC Biologics’ Yokohama site, a customer has already secured half of the facility’s manufacturing capacity.

Oktopi has received follow-on funding from the Gates Foundation, extending its original grant to advance OktoPilot, the platform's AI-agent

Study substantially exceeded enrollment target of 500 patients Topline results anticipated in Q1 2027 THE WOODLANDS, Texas, July 27, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc....

LOS ALTOS, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cheiron, the operating system for drug programs, today announced an $8 million seed round led by Menlo Ventures, with the backing and strategic...

Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with...

Dublin, July 15, 2026 (GLOBE NEWSWIRE) -- The "Biochemistry Analyzer Global Market Opportunities and Strategies to 2035" has been added to ResearchAndMarkets.com's offering. A comprehensive new...

AI Transforms Emerging Drug Development Through Faster Discovery and Smarter Clinical Trials

From 647 nominations globally, Hummingbird Bioscience emerged as a winner, recognizing the company’s AI-first approach to drug discovery and development.

First patient treated in Phase 2 A-TANGO trial of innovative combination treatment for acute-on-chronic liver failure